DrugPatentWatch

Competitive intelligence on small-molecule drugs and the 80,000 patents covering them

Simple flat-rate subscription plans

Ultimate Plan

$495/ month or  $2,495/ year

Tradename: QNASL

Summary for Tradename: QNASL

Patents:4
Applicants:1
NDAs:1
Suppliers: see list1
drug
patent expirations by year for
 QNASL

Pharmacology for Tradename: QNASL

Clinical Trials for: QNASL

A Study Evaluating the Effect of Inhaled and Nasal Corticosteroids on Short Term Growth in Pediatric Subjects With Mild Asthma & Allergic Rhinitis
Status: Recruiting Condition: Asthma; Allergic Rhinitis

The Effect of HFA - Beclomethasone Dipropionate Qvar on Bronchial Hyperreactivity in Preschool Children
Status: Completed Condition: Asthma; Bronchial Hyperresponsiveness

Effect of Flovent Discus vs QVAR vs Pulmicort Flexhaler on Short Term Growth
Status: Recruiting Condition: Asthma

Effects of QVAR in Smokers With Asthma
Status: Recruiting Condition: Asthma

Inhaled Extra-fine Hydrofluoalkane-beclomethasone (QVAR) in Premature Infants With Bronchopulmonary Dysplasia (BPD)
Status: Recruiting Condition: Bronchopulmonary Dysplasia

Real-life Effectiveness and Cost-effectiveness of Qvar Versus FP and BDP in the Management of COPD
Status: Completed Condition: Chronic Obstructive Pulmonary Disease

Bronchodilator Effect of CHF1535 pMDI Versus Free Combination of Beclometasone Plus Formoterol pMDI in Asthmatic Children
Status: Recruiting Condition: Asthma

A Comparison of Beclomethasone Aqueous Spray and Aerosol Delivery Systems in Nasal Polyps
Status: Recruiting Condition: Nasal Polyps

Qvar Versus Clenil, a General Practice Research Database Study
Status: Completed Condition: Asthma

Real-world Effectiveness and Cost-effectiveness of Qvar Versus FP, a US Study
Status: Completed Condition: Asthma

Courtesy of ClinicalTrials.org
See more clinical trials for this drug
Glossary
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Teva Branded Pharm
QNASL
beclomethasone dipropionate
AEROSOL, METERED;NASAL202813Mar 23, 2012RXYes<disabled><disabled>
Teva Branded Pharm
QNASL
beclomethasone dipropionate
AEROSOL, METERED;NASAL202813Mar 23, 2012RXYes5,605,674<disabled>Y<disabled>
Teva Branded Pharm
QNASL
beclomethasone dipropionate
AEROSOL, METERED;NASAL202813Mar 23, 2012RXYes5,683,677<disabled>Y<disabled>
Teva Branded Pharm
QNASL
beclomethasone dipropionate
AEROSOL, METERED;NASAL202813Mar 23, 2012RXYes5,776,432<disabled>Y<disabled>
This preview shows a limited data set
Complete access is available with a Subscription
first patents previous patents next patents last patents

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

DrugPatentWatch Archives

You are viewing the current data set
Select a link below to view the archives:

 2000  2001  2002  2003  2004  2005  2006  2007  2008  2009 
 2010  2011  2012  2013 

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Connect with Social Media:

Follow DrugPatentWatch on Twitter Connect with DrugPatentWatch on Linkedin Drug Patents on LinkedIn

Copyright © 2002-2014 thinkBiotech LLC. ISSN: 2162-2639

Other thinkBiotech sites: BiotechUBiotechBlogJournal of Commercial Biotechnology

`abc